May 26, 2022

Corneal Epithelial Thickness Mapping May Change Patients’ Eligibility for Refractive Surgery

Study finds that 11% of those originally deemed ineligible for LASIK are now candidates

22-EYE-2905316 CQD _ Eligibility for refractive surgery (Randleman)650X450_HERO

Evaluating patients for corneal refractive surgery eligibility is challenging, particularly because it’s crucial to recognize the subtleties of ectatic disease in its early stages. Additionally, these screenings, most of which use Placido-based corneal topography or Scheimpflug corneal tomography, are still mostly subjective. Corneal epithelial thickness mapping may add valuable insight into this process, according to a new study in the American Journal of Ophthalmology.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“Relatively few surgeons are currently using epithelial thickness maps,” says the study’s senior author J. Bradley Randleman, MD, of Cleveland Clinic Cole Eye Institute. “The pure practicality of how a practice would be changed if it had this device or not has never really been evaluated, so we wanted to take a look and see in a reasonably well-defined study how often our surgical decisions were changing.”

Re-evaluating 100 consecutive patients

High-frequency digital ultrasound and optical coherence tomography are both capable of producing a comprehensive epithelial thickness map. Dr. Randleman and colleague William J. Dupps, MD, PhD, routinely use Scheimpflug corneal tomography and epithelial thickness mapping in their clinical practice when evaluating patients for refractive surgery. The results are combined with patient-related factors (such as age, refractive error and corneal thickness) to determine surgical eligibility.

In the recent study, Drs. Randleman and Dupps re-evaluated (in a masked fashion) 100 consecutive patients who had been screened for refractive surgery at the Cole Eye Institute from February 2020 to September 2020. This re-evaluation took place six or more months after the patients’ initial clinical evaluation and imaging with both Scheimpflug tomography and anterior segment optical coherence tomography (AS-OCT).

The researchers independently assessed de-identified patient records for corneal refractive surgery eligibility using all of the initial evaluation information except the epithelial thickness maps from the AS-OCT imaging. They ranked surgical procedures — LASIK, PRK and SMILE — from most favorable to least favorable in terms of biomechanical impact on the patient’s cornea. Next, they looked at the patients’ epithelial thickness maps from the AS-OCT and reconsidered their evaluations.

Advertisement

Shown above: (A) Focally thin epithelium that would rule out laser vision correction; (B) Normal epithelial map; (C) Inferior epithelial hypertrophy that would rule in laser vision correction.

Surgical eligibility changed in 16% of patients

Overall, the researchers found that 82 of the 100 patients were candidates for corneal refractive surgery, with the remaining 18 patients determined ineligible. Eligibility for surgery changed in 16% of the patients after their epithelial thickness maps were considered — 10% initially deemed ineligible were screened in and 6% initially deemed eligible were screened out.

Additionally, the most favorable surgery for 16% of patients changed after their epithelial thickness maps were considered, and the ranking of the surgical procedures changed for 25% of patients. Eleven percent originally deemed poor candidates for LASIK were determined eligible, and 8% lost their eligibility for LASIK.

“We were surprised by the number of times the corneal thickness maps changed our surgical decisions,” says Dr. Randleman. “We thought the maps would add another level of confidence to our decision-making, but they were more impactful than we expected.”

Advertisement

More patients screened in rather than screened out

It’s important to note that the researchers used corneal epithelial thickness mapping to screen in two-thirds more patients than they ruled out, adds Dr. Randleman.

“Screening patients in is equally as important as screening patients out,” he says. “If you’re very conservative, you may be choosing not to operate on a good number of people who would benefit from surgery and from no longer wearing corrective lenses. Using epithelial mapping to screen more patients in is potentially beneficial to your practice as well as your patients.”

Related Articles

OCT scan showing dry AMD
March 19, 2024
Autoimmune Disease Linked With Higher Risk of Macular Degeneration

Early data shows risk is 73% higher in patients with lupus, 40% higher in patients with rheumatoid arthritis

Target with areas marked in different colors: blue, green and yellow
March 12, 2024
Motion-Tracking Brillouin Microscopy Detects Keratoconus Before It’s Clinically Evident

Identifies weak spots in the cornea before shape change occurs

23-EYE-4196362-inflammation-retinal-regeneration-CQD-Hero
September 19, 2023
Could Inflammation Be the Reason Why Human Retinas Don’t Regenerate?

Researchers to study retinal regeneration in zebrafish with new grant from National Eye Institute

23-EYE-4051658-CQD-ChatGPT-in-Ophthalmology-Research
August 14, 2023
Don’t Believe Everything Chatbots Say About Ophthalmic Research

30% of references generated by ChatGPT don’t exist, according to one study

22-EYE-3391159 CQD-Treating Retinoschisis-hero
December 23, 2022
Long-Term Topical Dorzolamide Improves Visual Acuity in Juvenile X-Linked Retinoschisis

Study followed patients an average of eight years

22-EYE-3066210 CQD-Losartan for corneal fibrosis-Wilson-hero
September 7, 2022
Hypertension Drug Losartan Reverses Scarring and Restores Vision After Cornea Damage

Studies indicate dramatic results when used topically with or without corticosteroids

22-EYE-3141638 CQD-EYP-1901 with vorolanib for maintenance of nAMD
August 23, 2022
DAVIO Trial Results: Vorolanib Injection Reduces Treatment Burden for Patients with nAMD

53% of participants didn’t need anti-VEGF for six months or longer

22-EYE-3049477 New findings in retinal regeneration-Perkins-650×450-4
August 3, 2022
Restoring the Retina: How to Regenerate Photoreceptors in Inherited Retinal Dystrophy

Notch pathway inhibition preserves retinal neurons and promotes regrowth in zebrafish

Ad